Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases

Diagnostics of autoimmune bullous diseases in German dermatology departments

(2012) Nina van Beek et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients

(2011) J.H. Kim et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients

(2011) M. Kasperkiewicz et al.   BRITISH JOURNAL OF DERMATOLOGY

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

(2011) M. Behzad et al.   BRITISH JOURNAL OF DERMATOLOGY

Low-dose rituximab is effective in pemphigus

(2011) B. Horváth et al.   BRITISH JOURNAL OF DERMATOLOGY

Evidence-Based Treatments in Pemphigus Vulgaris and Pemphigus Foliaceus

(2011) John W. Frew et al.   DERMATOLOGIC CLINICS

Autoimmune bullous skin diseases. Part 2: diagnosis and therapy

(2011) Andrea Kneisel et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients

(2011) Michael Kasperkiewicz et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

(2011) Hans-Peter Tony et al.   ARTHRITIS RESEARCH & THERAPY

Rituximab in Severe Pemphigus

(2009) Enno Schmidt et al.   Annals of the New York Academy of Sciences

B-Cell-Directed Therapy for Inflammatory Skin Diseases

(2009) Angela Nagel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

(2008) Martin Pfütze et al.   DERMATOLOGY

A review of the current use of rituximab in autoimmune diseases

(2008) Hakan M. Gürcan et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

(2008) Michael Hertl et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Rituximab Exerts a Dual Effect in Pemphigus Vulgaris

(2008) Rüdiger Eming et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY